The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Interleukin-10-deficient mice develop chronic enterocolitis
Kühn, R., Löhler, J., Rennick, D., Rajewsky, K., & Müller, W. (1993) · Cell · doi:10.1016/0092-8674(93)80068-p · Cited by 4,274
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., & Baldwin, A. S. (1995) · Science · doi:10.1126/science.270.5234.283 · Cited by 1,699
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
Neurath, M. F., Fuss, I., Kelsall, B. L., Stüber, E., & Strober, W. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1281 · Cited by 1,335
Self-citationPodolsky, D. K. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251306 · Cited by 1,231
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
Cited by
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
NF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567
Self-citationInflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
Butyrate inhibits inflammatory responses through NFκB inhibition: implications for Crohn's disease
Segain, J.-P., de la Blétière, D. R., Bourreille, A., Leray, V, Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H. M., & Galmiche, J.-P. (2000) · Gut · doi:10.1136/gut.47.3.397 · Cited by 1,321
Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05063-7 · Cited by 1,092
Series Introduction: The transcription factor NF-κB and human disease
Baldwin, A. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11891 · Cited by 990
The Role of Nuclear Factor- κ B in Cytokine Gene Regulation
Blackwell, T. S., & Christman, J. W. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.f132 · Cited by 955
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
NF‐κB in inflammatory bowel disease
Atreya, I., Atreya, R., & Neurath, M. F. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01953.x · Cited by 812
Self-citationA novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Activation of nuclear factor κB in inflammatory bowel disease
Schreiber, S., Nikolaus, S., & Hampe, J. (1998) · Gut · doi:10.1136/gut.42.4.477 · Cited by 750
Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B
Wahl, C., Liptay, S., Adler, G., & Schmid, R. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci992 · Cited by 742
Chen, F., Castranova, V., Shi, X., & Demers, L. M. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.1.7 · Cited by 718
Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa
Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Gross, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715
NF-κB is activated and promotes cell death in focal cerebral ischemia
Schneider, A., Martin-Villalba, A., Weih, F., Vogel, J., Wirth, T., & Schwaninger, M. (1999) · Nature Medicine · doi:10.1038/8432 · Cited by 645
TGF-β and fibrosis in different organs — molecular pathway imprints
Pohlers, D., Brenmoehl, J., Löffler, I., Müller, C. K., Leipner, C., Schultze-Mosgau, S., Stallmach, A., Kinne, R. W., & Wolf, G. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.06.004 · Cited by 576
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551
Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G. C., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041948 · Cited by 526
Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases
Pasparakis, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2655 · Cited by 523
NF-κB in the regulation of epithelial homeostasis and inflammation
Wullaert, A., Bonnet, M. C., & Pasparakis, M. (2011) · Cell Research · doi:10.1038/cr.2010.175 · Cited by 521
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
Caamaño, J., & Hunter, C. A. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.3.414-429.2002 · Cited by 510
Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses
Collins, L. V., Hajizadeh, S., Holme, E., Jonsson, I.-M., & Tarkowski, A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703328 · Cited by 508
Mouse models of inflammatory bowel disease☆
WIRTZ, S., & NEURATH, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.07.003 · Cited by 507
Self-citationNF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S.-C. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 489
Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis
Lührs, H., Gerke, T., Müller, J. G., Melcher, R., Schauber, J., Boxberger, F., Scheppach, W., & Menzel, T. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202317316105 · Cited by 464
Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.827 · Cited by 457
IL-1β and the Intestinal Epithelial Tight Junction Barrier
Kaminsky, L. W., Al-Sadi, R., & Ma, T. Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.767456 · Cited by 432
Rosenstiel, P., Fantini, M., Bräutigam, K., Kühbacher, T., Waetzig, G. H., Seegert, D., & Schreiber, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50157 · Cited by 422
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
Neurath, M. F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Büschenfelde, K., Strober, W., & Kollias, G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270722 · Cited by 413
Self-citationThe IKK/NF-κB activation pathway—a target for prevention and treatment of cancer
Greten, F. (2004) · Cancer Letters · doi:10.1016/j.canlet.2003.08.029 · Cited by 410
NF-κB Signaling Pathway, Inflammation and Colorectal Cancer
Wang, S., Liu, Z., Wang, L., & Zhang, X. (2009) · Cellular & Molecular Immunology · doi:10.1038/cmi.2009.43 · Cited by 405
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12131 · Cited by 395
The IκB/NF-κB system: a key determinant of mucosal inflammation and protection
Jobin, C., & Sartor, R. B. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.278.3.c451 · Cited by 386
NF-κB as a therapeutic target in chronic inflammation: recent advances
Makarov, S. S. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01814-1 · Cited by 379
Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease
Pavlick, K. P., Laroux, F. S., Fuseler, J., Wolf, R. E., Gray, L., Hoffman, J., & Grisham, M. B. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00853-5 · Cited by 373
panés, J., & Granger, D. N. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70328-2 · Cited by 370
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Role of NF-κB in immune and inflammatory responses in the gut
NEURATH, M. F., BECKER, C., & BARBULESCU, K. (1998) · Gut · doi:10.1136/gut.43.6.856 · Cited by 349
Self-citationBiologic therapy of inflammatory bowel disease
Sandborn, W. J., & Targan, S. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.33426 · Cited by 344
(2006) · Operative Pediatric Surgery 6Ed · doi:10.1201/b13237-67 · Cited by 341
Yao, D., Dong, M., Dai, C., & Wu, S. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz149 · Cited by 338
Hehner, S. P., Heinrich, M., Bork, P. M., Vogt, M., Ratter, F., Lehmann, V., Schulze-Osthoff, K., Dröge, W., & Schmitz, M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1288 · Cited by 338
Animal models of inflammatory bowel disease
Jurjus, A. R., Khoury, N. N., & Reimund, J.-M. (2004) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2003.12.002 · Cited by 336
Petrof, E. O., Kojima, K., Ropeleski, M. J., Musch, M. W., Tao, Y., De Simone, C., & Chang, E. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.001 · Cited by 330
Leukocyte‐endothelial cell adhesion: avenues for therapeutic intervention
Panés, J., Perry, M., & Granger, D. N. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702328 · Cited by 310
Beyaert, R., Heyninck, K., & Van Huffel, S. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00404-4 · Cited by 301
Weber, C. K., Liptay, S., Wirth, T., Adler, G., & Schmid, R. M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19458 · Cited by 299
Christman, J. W., Lancaster, L. H., & Blackwell, T. S. (1998) · Intensive Care Medicine · doi:10.1007/s001340050735 · Cited by 298
Ikappa Balpha -independent downregulation of NF-kappa B activity by glucocorticoid receptor
Heck, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.15.4698 · Cited by 295
Elewaut, D., DiDonato, J. A., Mogg Kim, J., Truong, F., Eckmann, L., & Kagnoff, M. F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1457 · Cited by 283
Murano, M., Maemura, K., Hirata, I., Toshina, K., Nishikawa, T., Hamamoto, N., Sasaki, S., Saitoh, O., & Katsu, K. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01183.x · Cited by 281
Schesser, K., Spiik, A., Dukuzumuremyi, J., Neurath, M. F., Pettersson, S., & Wolf‐Watz, H. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00851.x · Cited by 280
Self-citationFoell, D., Kucharzik, T., Kraft, M., Vogl, T., Sorg, C., Domschke, W., & Roth, J. (2003) · Gut · doi:10.1136/gut.52.6.847 · Cited by 279
Ruiz, P. A., Braune, A., Hölzlwimmer, G., Quintanilla-Fend, L., & Haller, D. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.5.1208 · Cited by 277
Myeloperoxidase in the inflamed colon: A novel target for treating inflammatory bowel disease
Chami, B., Martin, N. J. J., Dennis, J. M., & Witting, P. K. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.03.012 · Cited by 270
Camuesco, D., Comalada, M., Rodríguez‐Cabezas, M. E., Nieto, A., Lorente, M. D., Concha, A., Zarzuelo, A., & Gálvez, J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705941 · Cited by 268
Ukil, A., Maity, S., Karmakar, S., Datta, N., Vedasiromoni, J. R., & Das, P. K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705241 · Cited by 268
Animal Models of Inflammatory Bowel Disease
(2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394596-9.00009-3 · Cited by 267
Huschka, R., Barhoumi, A., Liu, Q., Roth, J. A., Ji, L., & Halas, N. J. (2012) · ACS Nano · doi:10.1021/nn301135w · Cited by 264
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice
Sugimoto, K., Hanai, H., Tozawa, K., Aoshi, T., Uchijima, M., Nagata, T., & Koide, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.37050 · Cited by 262
Kitani, A., Fuss, I., Nakamura, K., Kumaki, F., Usui, T., & Strober, W. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030917 · Cited by 260
Self-citationNairz, M., Schroll, A., Moschen, A. R., Sonnweber, T., Theurl, M., Theurl, I., Taub, N., Jamnig, C., Neurauter, D., Huber, L. A., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.002 · Cited by 194
Jin, W., Wang, H., Yan, W., Xu, L., Wang, X., Zhao, X., Yang, X., Chen, G., & Ji, Y. (2008) · Mediators of Inflammation · doi:10.1155/2008/725174 · Cited by 172
Distinct roles for the NF-κB1 (p50) and c-Rel transcription factors in inflammatory arthritis
Campbell, I. K., Gerondakis, S., O’Donnell, K., & Wicks, I. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8298 · Cited by 168
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157
Neves, A. R., Castelo-Branco, M. T. L., Figliuolo, V. R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H. F., Coutinho, C. M. L. M., Carneiro, A. J. V., Coutinho-Silva, R., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000441201.10454.06 · Cited by 107
“Levels of tumor necrosis factor-a-a and interleukin-1b increased after adenosine-triphosphate and decreased after KN62 treatment in CD. P2X7-R2/2 animals did not develop trinitrobenzene sulfonic acid or DSS colitis.”
BackgroundInfluentialProphylactic systemic P2X7 receptor blockade prevents experimental colitis
Marques, C. C., Castelo-Branco, M. T., Pacheco, R. G., Buongusto, F., do Rosário, A., Schanaider, A., Coutinho-Silva, R., & de Souza, H. S. P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.10.012 · Cited by 78
Haller, D., Holt, L., Parlesak, A., Zanga, J., Bäuerlein, A., Sartor, R. B., & Jobin, C. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01874.x · Cited by 54
Yoon, S.-B., Hong, H., Lim, H.-J., Choi, J. H., Choi, Y. P., Seo, S. W., Lee, H. W., Chae, C. H., Park, W.-K., Kim, H. Y., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.001 · Cited by 44
Ameliorating effect of hepatocyte growth factor on inflammatory bowel disease in a murine model
Oh, K., Iimuro, Y., Takeuchi, M., Kaneda, Y., Iwasaki, T., Terada, N., Matsumoto, T., Nakanishi, K., & Fujimoto, J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00438.2004 · Cited by 32
Huang, L., Kang, J., Chen, G., Ye, W., Meng, X., Du, Q., & Feng, Z. (2022) · Aging · doi:10.18632/aging.204290 · Cited by 23
Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases
Bhatia, D., Ardekani, M. S., Shi, Q., & Movafagh, S. (2017) · Hypoxia and Human Diseases · doi:10.5772/66089 · Cited by 17
Metadata
- Authors
- Neurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W.
- Venue
- Nature Medicine
- Published
- 1996-09
- Volume
- 2
- Issue
- 9
- Pages
- 998-1004
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1999855196
- Cited by
- 840
- References
- 44
- FWCI
- 24.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.